Global Genetic Toxicology Testing Market
Healthcare Services

Genetic Toxicology Testing Market Overview 2025: Competitive Shifts, Forecast Models, and Emerging Opportunities

Discover trends, market shifts, and competitive outlooks for the genetic toxicology testing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Key Projections for the CAGR of the Genetic Toxicology Testing Market Size From 2025 to 2034?

In recent years, the market size for genetic toxicology testing has witnessed substantial growth. The market is projected to expand from $1.63 billion in 2024 to $1.8 billion in 2025, with a compound annual growth rate (CAGR) of 10.4%. The significant growth during the historic period is due to several factors such as escalating public health emergencies, escalating globalization, heightened emphasis on personalized treatment, surging demand for rigorous testing solutions, and an upsurge in the number of drugs.

In the forthcoming years, swift expansion is predicted for the genetic toxicology testing market, expected to reach $2.64 billion by 2029 demonstrating a 10.0% compound annual growth rate (CAGR). Several factors are contributing to this increase during the forecast period such as increased testing of innovative foods, growing apprehension concerning potential hazards, amplified environmental and health fears, heightened regulatory investigation, a surge in the usage of in vitro testing techniques, and the emergence of high-throughput screening systems. Notable trends throughout this period include the evolution in precision medicine and toxicogenomics, wide-ranging risk dialogue, genetic toxicology testing methodologies, maturing risk evaluation methodologies, integration of omics technologies, and progression in genomics and molecular biology.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15574&type=smp

What are the Fundamental Drivers and Innovations Shaping the Genetic Toxicology Testing Market?

The genetic toxicology testing market is predicted to flourish with the rising demand for personalized medicine. This medical model, also known as personalized medicine, tailors healthcare strategies, practices, interventions, and products to match individual patients based on their anticipated response or disease risk. The growth of the personalized medicine market has been fueled by genetic advancements, a deeper comprehension of diseases, access to biomarker-based diagnostics, value-driven healthcare initiatives, and incorporation into clinical practice and research. Genetic toxicology testing plays a vital role in personalized medicine by offering critical data about genetic variability, susceptibility to genotoxic agents, and responsiveness to treatment. For example, the Personalized Medicine Coalition, a non-profit organization based in the United States, reported that in February 2024, 16 new personalized medicines were approved for patients with rare diseases, marking an increase from six approval in 2022. Hence, the escalating demand for personalized medicine stimulates the growth of the genetic toxicology testing market.

What Segment Types Define the Genetic Toxicology Testing Market Structure?

The genetic toxicology testing market covered in this report is segmented –

1) By Type: In Vitro, In Vivo

2) By Product: Services, Reagents And Consumables, Assays

3) By Application: Healthcare Industry, Food Industry, Cosmetics Industry, Agriculture Industry, Other Applications

Subsegments:

1) By In Vitro: Ames Test, Micronucleus Assay, Comet Assay, Chromosomal Aberration Test, Cell Transformation Assay, Other In Vitro Methods

2) By In Vivo: Micronucleus Test (Rodent), Comet Assay (In Vivo), Bone Marrow Chromosomal Aberration Test, Dominant Lethal Test (Rodent), Other In Vivo Methods

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15574&type=smp

Which Regions Are Driving the Next Phase of the Genetic Toxicology Testing Market Growth?

North America was the largest region in the genetic toxicology testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Trends Are Shaping the Future of the Genetic Toxicology Testing Market?

In an effort to enhance the precision and efficiency of genetic toxin identification, leading corporations in the genetic toxicology testing market are concentrating on creating innovative drug screening platforms, one of which is phenotypic drug screening. This screening approach is utilized in drug discovery, with compounds being tested for their capacity to produce a specific physiological or cellular response within an organism or relevant cell system. An example of this advancement was seen in August 2022 when Creative Biogene, a biotechnology company based in the United States, introduced zebrafish disease models to assist in drug discovery and toxicology research. These models have been developed to replicate human genetic diseases in zebrafish, offering valuable insights into disease pathogenesis, drug discovery, and toxicology. Creative Biogene’s zebrafish models serve as a valuable resource for evaluating drug toxicity, ensuring the safety of innovative compounds, and facilitating the drug development procedure.

View the full report here:

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

What Is the Definition of the Genetic Toxicology Testing Market?

Genetic toxicology testing is a branch of toxicology that focuses on assessing the potential of chemical substances to cause damage to genetic material, such as DNA, RNA, or chromosomes. The purpose of genetic toxicology testing is to evaluate the genotoxicity of compounds and identify any adverse effects they may have on the genetic material of living organisms, including humans. It is also a critical tool for evaluating the safety of pharmaceuticals, chemicals, and environmental pollutants from genotoxic hazards.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15574

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model